Vanguard Group Inc. Has $4.24 Billion Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Key Points

• Vanguard Group Inc. reduced its stake in Cardinal Health by 0.1%, selling 32,444 shares, and now owns approximately 12.88% of the company, valued at $4.2 billion.
• Several hedge funds increased their stakes in Cardinal Health, reflecting ongoing institutional interest, with 87.17% of the stock owned by institutional investors and hedge funds.
• Analysts have upgraded Cardinal Health's stock ratings, with price targets ranging from $156 to $190, reflecting a consensus rating of "Moderate Buy" with an average target of $158.07.

Vanguard Group Inc. trimmed its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 0.1% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 30,739,795 shares of the company's stock after selling 32,444 shares during the quarter. Vanguard Group Inc. owned about 12.88% of Cardinal Health worth $4,235,022,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of CAH. Bellwether Advisors LLC acquired a new position in Cardinal Health during the fourth quarter worth $32,000. Tompkins Financial Corp increased its position in Cardinal Health by 106.7% during the first quarter. Tompkins Financial Corp now owns 248 shares of the company's stock worth $34,000 after buying an additional 128 shares during the last quarter. Itau Unibanco Holding S.A. acquired a new position in Cardinal Health during the fourth quarter worth $36,000. GW&K Investment Management LLC increased its position in Cardinal Health by 113.4% during the first quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock worth $37,000 after buying an additional 144 shares during the last quarter. Finally, Measured Risk Portfolios Inc. acquired a new position in Cardinal Health during the fourth quarter worth $47,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Trading Up 2.6%

NYSE:CAH traded up $4.03 during mid-day trading on Friday, hitting $157.44. The company's stock had a trading volume of 1,634,303 shares, compared to its average volume of 1,771,020. Cardinal Health, Inc. has a fifty-two week low of $98.07 and a fifty-two week high of $168.44. The company has a market capitalization of $37.58 billion, a price-to-earnings ratio of 24.56, a P/E/G ratio of 1.56 and a beta of 0.67. The stock has a fifty day moving average of $160.05 and a 200-day moving average of $143.86.

Analysts Set New Price Targets

Several equities analysts have commented on CAH shares. Wall Street Zen downgraded shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 2nd. Morgan Stanley upped their price target on shares of Cardinal Health from $181.00 to $190.00 and gave the company an "overweight" rating in a report on Wednesday, July 16th. Evercore ISI restated an "outperform" rating and set a $180.00 price target (up from $175.00) on shares of Cardinal Health in a report on Thursday, June 12th. Bank of America upped their price target on shares of Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a report on Tuesday, June 10th. Finally, Robert W. Baird upped their price target on shares of Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a report on Friday, May 2nd. Three analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, Cardinal Health presently has an average rating of "Moderate Buy" and a consensus target price of $158.07.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.